09.02.2015 Views

Diseases and Management of Crops under Protected Cultivation

Diseases and Management of Crops under Protected Cultivation

Diseases and Management of Crops under Protected Cultivation

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(<strong>Diseases</strong> <strong>and</strong> <strong>Management</strong> <strong>of</strong> <strong>Crops</strong> <strong>under</strong> <strong>Protected</strong> <strong>Cultivation</strong>)<br />

Commercial Aspect <strong>of</strong> Biocontrol <strong>of</strong> Pest & <strong>Diseases</strong><br />

A.K. Tewari<br />

Department <strong>of</strong> Plant Pathology, G.B.P.U.A&T., Pantnagar- 263 145 (UK)<br />

The goal <strong>of</strong> biocontrol research is to provide additional tools for disease management. To<br />

place these tools in the growers’ h<strong>and</strong>s, products must be commercialized. The Bio-pesticide<br />

market is growing very rapidly. In 2005, bio-pesticides accounted for about 2.5% <strong>of</strong> the total<br />

pesticide market, which was merely 0.2% during 2000. This share is expected to grow to about<br />

5.2% by 2012. The contributions <strong>of</strong> bio-pesticides are important because, they <strong>of</strong>fer different<br />

modes <strong>of</strong> action from chemical pesticides <strong>and</strong> can, therefore, be applied in rotation with pesticides<br />

to reduce the possible development <strong>of</strong> pathogen resistance; pathogen resistance to fungicides has<br />

promoted interest in development <strong>of</strong> biocontrol agents; biocontrol can also be used in situations<br />

where currently no control is available or where conventional pesticides cannot be used due to<br />

reentry or residue concerns, or where the product must be certified organic; biocontrol can also be<br />

used in combination with reduced rates <strong>of</strong> pesticides. The relevance <strong>of</strong> biocontrol agents in plant<br />

pathology is still limited in spite <strong>of</strong> the great enthusiasm generated by researchers on biopesticides.<br />

It is due to over optimistic published papers on the subject; over emphasis <strong>of</strong> several<br />

partial results; exaggerated claims in the literature have over shadowed problems; most <strong>of</strong><br />

scientific reports are focused on selection <strong>of</strong> strains <strong>and</strong> basic biochemical studies <strong>and</strong> priority<br />

issues as mass production, formulation <strong>of</strong> biocontrol agents, toxicological <strong>and</strong> environmental<br />

safety <strong>and</strong> integration into other control strategies are not completely developed. These must be<br />

identified <strong>and</strong> solved by the researchers if BCAs have to find their rightful place among the<br />

different strategies <strong>of</strong> plant disease control. Biocontrol agents fail to become commercial products<br />

as scientists outside industry <strong>of</strong>ten overestimate the power <strong>of</strong> environmental concerns as<br />

economic drivers; lack sufficient knowledge <strong>of</strong> grower needs, registration strategy <strong>and</strong> competitive<br />

forces; have native ideas about positioning <strong>and</strong> market strategy; <strong>under</strong>estimate registration costs<br />

<strong>and</strong> difficulties <strong>and</strong> insufficient cost-performance <strong>and</strong> poor shelf life.<br />

Commercialization <strong>of</strong> bio-pesticides is a multi-step process involving a wide range <strong>of</strong><br />

activities. Broadly it falls into 3 main categories i.e. discoveries, development <strong>and</strong> registration.<br />

Most <strong>of</strong> the potentially useful microbial pesticides have been discovered by the scientists who<br />

have studied on a particular problem at site location in search <strong>of</strong> indigenous biocontrol agents.<br />

Presently industries do not develop the resources or incentives to discover a biocontrol agent in<br />

this manner. Therefore, the universities, government agencies <strong>and</strong> research foundation must play<br />

a significant role in the discovery <strong>of</strong> biocontrol agents. Once a biocontrol agent is identified with<br />

potential for commercialization, it enters the next phase towards commercialization, i.e.<br />

development phase.<br />

The development phase involves tests for efficacy, safety, specificity, test for genetic<br />

stability, potential for mass production, formulation, stability <strong>and</strong> shelf-life, delivery system,<br />

- 231 -

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!